Get the Stockscreener App
68.60
1.17%
-0.81
After Hours:
68.60
Solventum Corp stock is traded at $68.60, with a volume of 1.34M.
It is down -1.17% in the last 24 hours and down -12.13% over the past month.
Solventum Corp is a healthcare company developing, manufacturing, and commercializing solutions leveraging material science, data science, and digital capabilities to address customer and patient needs. Its segments include MedSurg, which earns maximum revenue and provides wound therapy, I.V. site management, surgical supplies, medical tapes and wraps, stethoscopes, medical electrodes, and OEM medical technologies; Dental Solutions, offering dental and orthodontic products such as brackets, restorative cements, and bonding agents; and Health Information Systems, providing software solutions including physician documentation, coding automation, speech recognition, and data visualization platforms. It operates in the United States, which earns the majority of revenue, and internationally.
See More
Previous Close:
$69.41
Open:
$68.29
24h Volume:
1.34M
Relative Volume:
1.24
Market Cap:
$11.90B
Revenue:
$8.42B
Net Income/Loss:
$1.52B
P/E Ratio:
7.8968
EPS:
8.6871
Net Cash Flow:
$56.00M
1W Performance:
-6.03%
1M Performance:
-12.13%
6M Performance:
-5.90%
1Y Performance:
-11.97%
1-Day Range:
$66.61
$68.84
1-Week Range:
$66.61
$72.16
52-Week Range:
$60.70
$88.20
Solventum Corp Stock (SOLV) Company Profile
Name
Solventum Corp
Sector
Industry
Phone
651-733-1110
Address
C/O 3M COMPANY, ST. PAUL
Compare SOLV vs ISRG, BDX, ALC, RMD, MDLN
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SOLV
Solventum Corp
|
68.60 | 12.04B | 8.42B | 1.52B | 56.00M | 8.6871 |
|
ISRG
Intuitive Surgical Inc
|
493.56 | 174.07B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
165.46 | 47.54B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
ALC
Alcon Inc
|
81.85 | 39.64B | 10.40B | 980.00M | 1.61B | 1.9749 |
|
RMD
Resmed Inc
|
252.93 | 36.84B | 5.40B | 1.49B | 1.78B | 10.12 |
|
MDLN
Medline Inc
|
43.41 | 35.57B | 28.43B | 1.16B | 1.26B | 1.4457 |
Solventum Corp Stock (SOLV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-26-26 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Jan-20-26 | Upgrade | Mizuho | Neutral → Outperform |
| Dec-02-25 | Upgrade | BTIG Research | Neutral → Buy |
| Oct-01-25 | Initiated | UBS | Neutral |
| Sep-11-25 | Initiated | Jefferies | Hold |
| Jul-15-25 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Jul-01-25 | Upgrade | Argus | Hold → Buy |
| Jun-06-25 | Initiated | KeyBanc Capital Markets | Sector Weight |
| May-19-25 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-04-24 | Initiated | Mizuho | Neutral |
| Oct-08-24 | Initiated | Stifel | Buy |
| Oct-07-24 | Initiated | Piper Sandler | Neutral |
| Sep-26-24 | Initiated | Wolfe Research | Peer Perform |
| Sep-05-24 | Initiated | BTIG Research | Neutral |
| Jun-24-24 | Initiated | Argus | Hold |
| May-30-24 | Initiated | Goldman | Sell |
| May-10-24 | Initiated | BofA Securities | Neutral |
| Apr-10-24 | Initiated | Morgan Stanley | Equal-Weight |
| Apr-08-24 | Initiated | Wells Fargo | Equal Weight |
| Apr-02-24 | Initiated | Edward Jones | Hold |
View All
Solventum Corp Stock (SOLV) Latest News
Will Solventum's (SOLV) Strong Q4, 2026 Outlook and Buyback Shift Its Capital Allocation Narrative - simplywall.st
Solventum’s Post-Spin Discount Looks Big, But Growth Must Show Up - Finimize
A Look At Solventum (SOLV) Valuation After Q4 2025 Earnings Beat And 2026 Outlook Update - simplywall.st
The Turnaround Titan Leads Solventum to Success - Medical Device and Diagnostic industry
Solventum outlines 2026 organic sales growth of 2%-3% while advancing portfolio optimization and margin expansion - MSN
Solventum (SOLV) Q4 2025 Adjusted Diluted EPS Reaches $1.57 on 3.5% Organic Sales Growth - Finviz
Solventum Corp. stock falls Tuesday, underperforms market - MarketWatch
Solventum (SOLV) is Among the Highest-Rated Value Stocks: Is It Worth Purchasing? - Bitget
SOLV Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Commit To Purchase Solventum At $65, Earn 11.6% Annualized Using Options - Nasdaq
Solventum : Shareholder Letter Q4 2025 - marketscreener.com
Solventum Stock: Improvements Come Slow (NYSE:SOLV) - Seeking Alpha
Solventum Corp. stock falls Monday, underperforms market - MarketWatch
UBS Adjusts Solventum Price Target to $82 From $79, Maintains Neutral Rating - marketscreener.com
Solventum’s High-Stakes Restructuring: Profitability Ambitions Face Significant Execution Risks - The Globe and Mail
Solventum Corporation (SOLV) Stock Analysis: A 21% Upside Potential Amidst Mixed Signals - DirectorsTalk Interviews
Solventum Corporation $SOLV Shares Purchased by Mitsubishi UFJ Asset Management Co. Ltd. - MarketBeat
Will Solventum's (SOLV) $1 Billion Buyback and Strong 2025 Earnings Redefine Its Capital Story? - Sahm
Solventum Earnings Call Balances Growth With Headwinds - TipRanks
Solventum Sets Confident Course with Strategic Overhaul and 2026 Guidance - AD HOC NEWS
SOLV PE Ratio & Valuation, Is SOLV Overvalued - Intellectia AI
A Look At Solventum (SOLV) Valuation After Earnings Beat Buyback Plan And Growth Guidance - Yahoo Finance
Andra AP fonden Has $8.04 Million Holdings in Solventum Corporation $SOLV - MarketBeat
Solventum Q4 Earnings Call Highlights - MarketBeat
Is It Time To Reassess Solventum (SOLV) After The 3M Separation? - simplywall.st
US Bancorp DE Has $31.04 Million Stock Position in Solventum Corporation $SOLV - MarketBeat
Solventum (NYSE:SOLV) Rating Increased to Buy at Wall Street Zen - MarketBeat
Clover Health, Alignment Healthcare, Solventum, ANI Pharmaceuticals, and Guardant Health Shares Plummet, What You Need To Know - The Globe and Mail
Piper Sandler reiterates Solventum stock rating on revenue growth By Investing.com - Investing.com South Africa
Solventum Q4 FY25 slides: organic growth solid despite earnings miss By Investing.com - Investing.com Australia
Solventum (SOLV) One Off US$1.5b Gain Raises Questions For Bullish Margin Narratives - simplywall.st
Solventum Corp. stock falls Friday, underperforms market - MarketWatch
SOLV: BTIG Reiterates 'Buy' Rating with Price Target Unchanged a - GuruFocus
Solventum Dental Solutions Sales Grow 8.6% in Q4 - Orthodontic Products
Solventum Corp SEC 10-K Report - TradingView
Solventum (NYSE:SOLV) Given New $83.00 Price Target at Wells Fargo & Company - MarketBeat
Solventum Stock Down Despite Q4 Earnings & Revenues Beat, Margins Down - Yahoo Finance
Solventum Corp (SOLV) Shares Gap Down to $74.47 on Feb 27 - GuruFocus
Solventum Beat Wall Street Earnings Estimates. The Stock Is Down. - Barron's
Solventum (SOLV) Maintains Overweight Rating with Raised Price T - GuruFocus
Solventum (NYSE:SOLV) Stock Price Expected to Rise, KeyCorp Analyst Says - MarketBeat
Solventum (NYSE:SOLV) Given Buy Rating at BTIG Research - MarketBeat
Piper Sandler reiterates Solventum stock rating on revenue growth - Investing.com
Solventum Beat Wall Street Earnings Estimates. The Stock Falls. - Barron's
KeyBanc Adjusts Price Target on Solventum to $99 From $97, Maintains Overweight Rating - marketscreener.com
Demystifying Solventum: Insights From 5 Analyst Reviews - Benzinga
Jefferies Adjusts Price Target on Solventum to $84 From $75, Maintains Hold Rating - marketscreener.com
Solventum beats quarterly estimates on strong demand for surgical products - WHTC
Solventum (SOLV) Q4 2025 Earnings Call Transcript - Fortune
Solventum exceeds earnings estimates in first year as solo company - MassDevice
Solventum (NYSE:SOLV) Releases Quarterly Earnings Results, Beats Expectations By $0.07 EPS - MarketBeat
Solventum Corp Stock (SOLV) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.60%
0.95%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):